Follow
Erik van Dijk
Erik van Dijk
Postdoctoral researcher, Amsterdam UMC
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
The hydrophobic temperature dependence of amino acids directly calculated from protein structures
E van Dijk, A Hoogeveen, S Abeln
PLoS Comput Biol 11 (5), e1004277, 2015
1462015
Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts
M van der Heijden, DM Miedema, B Waclaw, VL Veenstra, MC Lecca, ...
Proceedings of the National Academy of Sciences 116 (13), 6140-6145, 2019
642019
Coarse-grained vs. atomistic simulations: realistic interaction free energies for real proteins
A May, R Pool, E van Dijk, J Bijlard, S Abeln, J Heringa, KA Feenstra
Bioinformatics, btt675, 2013
552013
Chromosomal copy number heterogeneity predicts survival rates across cancers
E van Dijk, T Van Den Bosch, KJ Lenos, K El Makrini, LE Nijman, ...
Nature communications 12 (1), 3188, 2021
542021
The hydrophobic effect characterises the thermodynamic signature of amyloid fibril growth
JHM Van Gils, E Van Dijk, A Peduzzo, A Hofmann, N Vettore, ...
PLoS computational biology 16 (5), e1007767, 2020
412020
Consistent treatment of hydrophobicity in protein lattice models accounts for cold denaturation
E Van Dijk, P Varilly, TPJ Knowles, D Frenkel, S Abeln
Physical review letters 116 (7), 078101, 2016
402016
Computational screening of tip and stalk cell behavior proposes a role for apelin signaling in sprout progression
MM Palm, MG Dallinga, E van Dijk, I Klaassen, RO Schlingemann, ...
PloS one 11 (11), e0159478, 2016
38*2016
Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma
GT Los-de Vries, M De Boer, E van Dijk, P Stathi, NJ Hijmering, ...
Blood, The Journal of the American Society of Hematology 136 (25), 2927-2932, 2020
372020
Loss of chromosome 18q11. 2-q12. 1 is predictive for survival in patients with metastatic colorectal cancer treated with bevacizumab
E Van Dijk, HD Biesma, M Cordes, D Smeets, M Neerincx, S Das, PP Eijk, ...
Journal of Clinical Oncology 36 (20), 2052-+, 2018
342018
Molecular characterization of colorectal cancer related peritoneal metastatic disease
KJ Lenos, S Bach, L Ferreira Moreno, S Ten Hoorn, NR Sluiter, ...
Nature communications 13 (1), 4443, 2022
332022
Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma
EEE Drees, MGM Roemer, NJ Groenewegen, J Perez‐Boza, ...
Journal of extracellular vesicles 10 (9), e12121, 2021
242021
The characteristics of molten globule states and folding pathways strongly depend on the sequence of a protein
MJJ Dijkstra, WJ Fokkink, J Heringa, E van Dijk, S Abeln
Molecular Physics 116 (21-22), 3173-3180, 2018
202018
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment
JJ Beagan, S Bach, RA van Boerdonk, E van Dijk, E Thunnissen, ...
Lung Cancer 145, 173-180, 2020
182020
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
GT Los-de Vries, WBC Stevens, E van Dijk, C Langois-Jacques, AJ Clear, ...
Blood advances 6 (18), 5482-5493, 2022
162022
How sticky are our proteins? Quantifying hydrophobicity of the human proteome
JHM van Gils, D Gogishvili, J van Eck, R Bouwmeester, E van Dijk, ...
Bioinformatics advances 2 (1), vbac002, 2022
92022
PCR-free shallow whole genome sequencing for chromosomal copy number detection from plasma of cancer patients is an efficient alternative to the conventional PCR-based approach
JJ Beagan, EEE Drees, P Stathi, PP Eijk, L Meulenbroeks, F Kessler, ...
The Journal of Molecular Diagnostics 23 (11), 1553-1563, 2021
92021
A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma
M Mendeville, J Janssen, Y Kim, E van Dijk, D de Jong, B Ylstra
Leukemia 36 (9), 2177-2179, 2022
62022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
CI Stroes, S Schokker, M Khurshed, SO van der Woude, RAA Mathôt, ...
Therapeutic advances in medical oncology 14, 17588359221109196, 2022
32022
SPECIFIC GENETIC ALTERATIONS CHARACTERIZE SEROMA‐AND TUMOR‐TYPE BREAST‐IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA‐ALCL) AS A DISTINCT DISEASE ENTITY
B Ylstra, GT Los‐de Vries, M de Boer, E van Dijk, P Stathi, N Hijmering, ...
Hematological Oncology 37, 201-202, 2019
22019
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
S Ten Hoorn, L Mol, DW Sommeijer, L Nijman, T van den Bosch, ...
Clinical Colorectal Cancer 22 (1), 67-75, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20